CVM (CEL-SCI Corp) Wutah bathi resik saben saham ing taun iki
CEL-SCI Corporation conducts its development within a stable US legal framework, which minimizes operational risks. Annual EPS variation reflects current dynamics, where the 0.00 mark records this metric. This figure is influenced by prolonged immunotherapy trials and patent dependency, as well as global conflicts, which often slow down the operations of research centers and complicate the export of new drugs.
Rincian analitis lan laporan data perusahaan CEL-SCI Corporation (CVM)
- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
- rincian nilai buku perusahaan:
- indikator beban utang lan likuiditas:
Rasio Utang marang Modal CEL-SCI Corporation|CVM - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal CEL-SCI Corp.|CVM - Gunggung utang perusahaan|Utang marang nilai buku CEL-SCI|CVM - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak CEL-SCI|Rasio jangkoan perantara cel-sci.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CVM - Bathi resik|Bathi mangsa ngarep CEL-SCI Corporation|CVM - Rasio rega marang bathi|Rasio prakiraan rega marang bathi CEL-SCI Corp|CVM - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan CEL-SCI Corporation|CVM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan CEL-SCI|CVM - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan cel-sci.com|CVM - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep CEL-SCI Corporation
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental:CVM, CEL-SCI Corporation
Investors are seeking a fundamental anchor in assets characterized by high uncertainty. The CEL-SCI Corporation (CVM) model is based on capital-intensive R&D developments in the absence of current sales. The 12-month earnings per share (EPS) growth rate measures the dynamics of net income per share relative to the previous year. This indicator captures the rate at which the company's cash reserves are depleting, allowing for an objective assessment of the asset's impairment risk.
Pesaing langsung
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Y-mAbs Therapeutics, Inc. (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki AURA|Kacepetan wutah bathi saben saham ing taun lumaku candeltx.com CADL|Wutah bathi ing taun lumaku ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics Inc)|Tambahing bathi saben saham ing taun lumaku CTOR|tuhurabio.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Wutah bathi saben saham ing taun lumaku|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku tscan.com|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku XBiotech USA (XBIT)|OSTX - Kacepetan wutah bathi saben saham ing taun lumaku|Radiopharm Theranostics - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku ARTV|ANL - Wutah bathi saben saham ing taun lumaku|VERU - Wutah bathi ing taun lumaku|Tempest Therapeutics, Inc. (TPST) - Wutah bathi saben saham ing taun lumaku|XLO: Wutah bathi resik saben siji saham kanggo taun lumaku|RENB (Renovaro Biosciences) - Wutah bathi ing taun lumaku|MURA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki KAPA (Kairos Pharma Ltd)|Wutah bathi resik saben siji saham kanggo taun lumaku OKUR|CytoMed Therapeutics Limited - Wutah bathi resik saben saham ing taun iki|CRIS: Wutah bathi saben saham ing taun iki|APLM - Wutah bathi saben saham ing taun lumaku|THAR - Wutah bathi ing taun lumaku|ADVB: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku SBFM|Wutah bathi ing taun lumaku XBIO|Wutah bathi resik saben saham ing taun iki Salarius Pharmaceuticals SLRX|Wutah bathi ing taun lumaku PPBT (Purple Biotech Ltd)|AONC - Wutah bathi resik saben saham ing taun iki|BGNE: Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun iki Checkpoint Therapeutics, Inc CKPT|ELEV: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku iCAD Inc. (ICAD)|IKNA (Ikena) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Notable Labs (NTBL)|Wutah bathi ing taun lumaku VIRX|Wutah bathi resik saben saham ing taun iki MorphoSys Corporation MOR|NAYA Biosciences - Wutah bathi resik saben saham ing taun iki|Owah-owahan bathi resik saben saham ing taun lumaku Ascentage Pharma
